# Reevaluating Electroencephalography Monitoring in Koolen-de Vries Syndrome: A Case of Delayed Focal Impaired Consciousness Seizure Diagnosis

**Authors:** Ryan Nazari, Manav Nayeni, Pavan Sakhamuru, Anuj Gupta, Charles V Moylan

PMC · DOI: 10.7759/cureus.83693 · Cureus · 2025-05-07

## TL;DR

A case study shows how EEG monitoring helped diagnose delayed focal impaired consciousness seizures in a child with Koolen-de Vries syndrome.

## Contribution

Highlights the importance of EEG in diagnosing FICS in Koolen-de Vries syndrome patients with ambiguous symptoms.

## Key findings

- EEG revealed frequent focal sharp waves consistent with FICS in a KdVS patient.
- Treatment with diazepam and amantadine improved neurological status significantly.
- Early EEG use is crucial for diagnosing seizures in KdVS patients with non-specific symptoms.

## Abstract

Koolen-de Vries syndrome (KdVS) is a rare multisystem genetic disorder due to deletions in the KANSL1 gene. The most common type of seizure documented in these patients is focal impaired consciousness seizure (FICS). These seizures present with difficult-to-distinguish characteristics, including autonomic symptoms, brief loss of consciousness, and post-ictal confusion. The ambiguity of this presentation can make it difficult to detect clinically. This case presents an eight-year-old male child with KdVS who presented to the clinic with complaints of increased outbursts, spatial disorientation, issues with mood and self-regulation, and episodes of “spacing out” as noted by his teacher. The initial diagnosis was dysautonomia and was conservatively managed. However, due to worsening neurocognitive outcomes, neurological referral and work-up were initiated to further elucidate the etiology of his symptoms. The patient's electroencephalography (EEG) findings showed frequent focal sharp waves consistent with FICS. He was then treated accordingly with diazepam and amantadine, which led to a significant improvement in neurological status. This case highlights the importance of the use of EEG in KdVS patients, as well as the implications of implementing guidelines recommending the low threshold required for use of EEG and full neurological work-up for patients with any alarm symptoms possibly indicative of FICS or other epileptiform activity.

## Linked entities

- **Genes:** KANSL1 (KAT8 regulatory NSL complex subunit 1) [NCBI Gene 284058]
- **Chemicals:** diazepam (PubChem CID 3016), amantadine (PubChem CID 2130)
- **Diseases:** Koolen-de Vries syndrome (MONDO:0012496), dysautonomia (MONDO:0001292)

## Full-text entities

- **Genes:** KANSL1 (KAT8 regulatory NSL complex subunit 1) [NCBI Gene 284058] {aka C17DELq21.31, CENP-36, DEL17Q21.31, KDVS, KIAA1267, MSL1v1}
- **Diseases:** epileptiform (MESH:D014277), loss of consciousness (MESH:D014474), confusion (MESH:D003221), seizure (MESH:D012640), FICS (MESH:D004828), dysautonomia (MESH:D054969), KdVS (MESH:C566476), genetic disorder (MESH:D030342)
- **Chemicals:** amantadine (MESH:D000547), diazepam (MESH:D003975)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12144403/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12144403/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12144403/full.md

---
Source: https://tomesphere.com/paper/PMC12144403